b'Hor ningDr. Sandra2020-2021 WOMANOF THE YEARFORMER CHIEF MEDICAL OFFICER AND HEAD OF GLOBAL PRODUCT DEVELOPMENT, GENENTECH AND ROCHEWith more than 30 years in the field, Dr. Horning has been a constant advocate for evidence-based treatment, helping to establish standards of care for patients across all types of Hodgkin and non-Hodgkin lymphoma. She has garnered prolific status as a researcher, leader and educator recognized with a prestigious Stanford School of Medicine Excellence in Patient Care Award, among many other honors. Dr. Horning served as executive vice president, chief medical officer and head of global product development for Genentech and Roche from January 2014 through October 2019 and earlier was senior vice president, global head of oncology clinical science. During her tenure at Genentech and Roche, she was a driving force behind the largest, most diverse scientific portfolio in the biotechnology industry. Her commitment and work resulted in delivering 15 new medicines to patients in neuroscience, ophthalmology, immunology, infectious disease and hematology/oncology. Currently she serves on the board of directors of Gilead Sciences, Moderna and Olema Oncology, and she is a co-founder and board member of EQRx.10'